Phase 2 Lung Cancer Trial, Recruiting (NCT07559097)

Phase 2 Lung Cancer Trial, Recruiting NCT07559097 Sponsor: Henan Cancer Hospital Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07559097 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You have been diagnosed with lung cancer confirmed by a tissue sample or cell test (biopsy or cytology)
You have been diagnosed with cancer that has spread to the membranes surrounding the brain and spinal cord, confirmed by finding cancer cells in the fluid around your spine
You have advanced lung cancer with this type of spread, and previous standard treatments have not worked
Your general health and ability to carry out daily activities falls within a certain range — not too severely limited (confirm with trial site for exact fitness level required)

Who may not be able to join:

You currently have an infection in your brain or central nervous system
Your general health and daily functioning is severely limited (confirm with trial site for exact fitness level that would exclude you)
You are currently taking part in another clinical trial that involves a treatment or intervention
You have a history of, or currently have, a serious condition that weakens your immune system
The trial doctor decides, for any other reason, that the trial would not be suitable for you

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07559097

Sponsor: Henan Cancer Hospital

Phase: Phase 2

Status: Recruiting

Condition: Lung Cancer

More information: https://clinicaltrials.gov/study/NCT07559097

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You have been diagnosed with lung cancer confirmed by a tissue sample or cell test (biopsy or cytology)
You have been diagnosed with cancer that has spread to the membranes surrounding the brain and spinal cord, confirmed by finding cancer cells in the fluid around your spine
You have advanced lung cancer with this type of spread, and previous standard treatments have not worked
Your general health and ability to carry out daily activities falls within a certain range — not too severely limited (confirm with trial site for exact fitness level required)

Who may not be able to join:

You currently have an infection in your brain or central nervous system
Your general health and daily functioning is severely limited (confirm with trial site for exact fitness level that would exclude you)
You are currently taking part in another clinical trial that involves a treatment or intervention
You have a history of, or currently have, a serious condition that weakens your immune system
The trial doctor decides, for any other reason, that the trial would not be suitable for you

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Henan Cancer Hospital

Registry

ClinicalTrials.gov

Start date

8 September 2025

Est. completion

31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Phase I: Maximum Tolerated Dose (MTD) and Recommended Phase II Dose (RP2D); Phase II:Objective Response Rate(ORR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov